|
|
||||||||
Ann Thorac Surg 1984;37:141-146
© 1984 The Society of Thoracic Surgeons
From the Department of Surgery, Division of Thoracic and Cardiovascular Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
Accepted for publication May 18, 1983.
* Address reprint requests to Dr. Landymore, Room 119, Pavilion, Victoria General Hospital, Halifax, Nova Scotia, Canada B3H 2Y9
Twenty-four mongrel dogs were divided into two equal groups to determine the effects of orally administered amiodarone on left ventricular function. Measurements of left ventricular function included left ventricular contractility as denoted by maximum rate of rise of left ventricular pressure (dP/dtmax), cardiac index (CI), left ventricular stroke work index (LVSWI), and peripheral vascular resistance (PVR). Left ventricular function was measured in 6 of the 12 animals in Group 1 before and after 14 days of amiodarone administered orally; the remaining animals served as controls. The dP/dtmax was reduced from 2,855 to 1,291 mm Hg/sec (p < 0.01), and LVSWI fell from 1.6 to 0.74 gm-m/beat/kg (p < 0.05) in the 6 animals given amiodarone.
The 12 animals in Group 2 underwent 30 minutes of ischemic arrest. Six animals in Group 2 underwent 30 minutes of ischemic arrest. Six animals were given amiodarone orally for 14 days prior to cardiopulmonary bypass and ischemic arrest; the other 6 served as controls. Before cardiopulmonary bypass, the dogs administered amiodarone had significantly greater depression of dP/dtmax (p < 0.01) and LVSWI (p < 0.05). Thirty minutes of ischemia produced significant depression of left ventricular function in all animals in Group 2. However, a significantly greater reduction in dP/dtmax and LVSWI occurred in those animals receiving amiodarone. Furthermore, 4 of the 6 dogs receiving amiodarone were unable to sustain sufficient cardiac output following cardiopulmonary bypass to permit long-term survival (p < 0.05). These data demonstrate that the oral administration of amiodarone results in a significant depression of left ventricular function and suggest that amiodarone should be used with caution in patients with impaired left ventricular function.
This article has been cited by other articles:
![]() |
L. L. Mickleborough, H. Maruyama, S. Mohamed, D. C. Rappaport, E. Downar, J. Butany, and Z. Sun Are patients receiving amiodarone at increased risk for cardiac operations? Ann. Thorac. Surg., September 1, 1994; 58(3): 622 - 629. [Abstract] [PDF] |
||||
![]() |
J. A. Karlson, R. W. Hopkins, J. M. Moran, and K. E. Karlson Long-term amiodarone administration protects against global myocardial ischemia Ann. Thorac. Surg., October 1, 1990; 50(4): 575 - 578. [Abstract] [PDF] |
||||
![]() |
R. W. Landymore, A. E. Marble, A. Trillo, G. Faulkner, M. A. MacAulay, and C. Cameron Prevention of Myocardial Electrical Activity during Ischemic Arrest with Verapamil Cardioplegia Ann. Thorac. Surg., May 1, 1987; 43(5): 534 - 538. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |